[New anti-migraine drugs used in the treatment of children and adolescents].
In recent years a number of new preparations from the group of antiserotonin agents (including cyproheptadine and carbazochrome) as well as beta-adrenergic blocking agents (propranolol) and clonidine have been introduced for prevention of migraine and similar headaches. The efficiency of these drugs was studied in a group of 9 selected cases--adolescents with severe migraine refractory to other methods of treatment. In 7 cases the improvement was noted. The results were compared with own observations on larger groups of adults and data from literature. Too small number of observed patients made impossible definite conclusions. It seems, however that in selected cases the use of these drugs in headaches of adolescents is useful.
D000293:Adolescent; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000323:Adrenochrome / Q000627:therapeutic use; D002648:Child; D003000:Clonidine / Q000627:therapeutic use; D003533:Cyproheptadine / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008881:Migraine Disorders / Q000188:drug therapy*; D012702:Serotonin Antagonists / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D012702:Serotonin Antagonists; D003533:Cyproheptadine; D000323:Adrenochrome; D003000:Clonidine
Niektóre nowsze leki przeciwmigrenowe i ich zastosowanie w bólach głowy u młodziezy. Doniesienie wstepne.